Vir Biotechnology, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.1 | $0.1 | $0.1 | $1.6 | $1.1 |
| Operating income | -$0.5 | -$0.6 | -$0.7 | $0.8 | $0.4 |
| Net income | -$0.4 | -$0.5 | -$0.6 | $0.5 | $0.5 |
| Cash Flow Statement | |||||
| Free cash flow | -$0.4 | -$0.5 | -$0.8 | $1.6 | -$0.1 |
Shares outstanding 169.2M · Free float 81.5%
Annual filing data through FY ended December 31, 2025; float as of October 3, 2026.